Target intelligence / Profile preview

HtrA serine peptidase 4 (HTRA4)

Target
HTRA4
Molecular classification
Enzyme, Serine protease, Endopeptidase, HtrA protease family
01

Overview

HtrA serine peptidase 4 (HTRA4) is a member of the HtrA family of serine proteases characterized by the presence of a signal peptide, an insulin-like growth factor binding domain, a Kazal protease inhibitor domain, a trypsin-like serine protease domain, and a PDZ domain[1][3]. It is thought to function as a secreted chaperone protease, degrading misfolded secretory proteins, and is associated with endopeptidase activity[1][4]. Although HTRA4 is less characterized than other family members, some roles in inhibiting endothelial repair and pregnancy disorders such as preeclampsia have been noted[5]. Expression in humans is primarily restricted to the placenta[3]. Family members of HtrA have been linked to functions such as protein quality control and responses to cell stress, and disease associations including cancer, arthritis, apoptosis, and aging, though direct links for HTRA4 remain limited[1][2].

Other names
Serine protease HTRA4FLJ90724High-temperature requirement factor A4HTRA4probable serine protease HTRA4
02

Mechanism of action

Protease inhibition (by analogy to other family members) No specific drug mechanism reported

03

Biological functions

Protein quality control (degrades misfolded secretory proteins)Serine-type endopeptidase activityInsulin-like growth factor bindingPotential cell stress response
04

Disease associations

Preeclampsia (pregnancy complication)Other (family implicated in arthritis, tumor suppression, unfolded protein response, apoptosis, aging)
05

Biomarkers

HTRA4 may be investigated as a biomarker for preeclampsia

Beyond the preview

Go deeper on HtrA serine peptidase 4 (HTRA4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HtrA serine peptidase 4 (HTRA4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call